Overview
Navi Medical Technologies is an Australian medtech company developing paediatric technology aimed at clinical commercialization in the United States. The company is positioned in healthcare AI and medical devices, with a focus on bringing specialized technology for children into hospital settings. The company raised a Series A round reported at $7 million, with the round described as A$6.8 million, to support commercialization of its breakthrough paediatric technology in the U.S. The financing underscores investor interest in Australian healthcare innovation with global market potential.
Funding History
Australian medtech Navi raises $A6.8 million to commercialise breakthrough paediatric technology in the US
Frequently Asked Questions
- How much funding does AI Funding track for Navi Medical Technologies?
- AI Funding tracks $7M for Navi Medical Technologies across 1 funding round in this database.
- What does Navi Medical Technologies do?
- Navi Medical Technologies is an Australian medtech company developing paediatric technology aimed at clinical commercialization in the United States. The company is positioned in healthcare AI and medical devices, with a focus on bringing specialized technology for children into hospital settings. The company raised a Series A round reported at $7 million, with the round described as A$6.8 million, to support commercialization of its breakthrough paediatric technology in the U.S. The financing underscores investor interest in Australian healthcare innovation with global market potential.
- Where is Navi Medical Technologies headquartered?
- Navi Medical Technologies is headquartered in Melbourne, Australia.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.